Phil Jones, Ph.D. | Navire - Navire Pharma
Philip Jones is the executive director and head of drug discovery at the Institute for Applied Cancer Science within MD Anderson Cancer Center. He has nearly two decades of drug discovery and development experience, nearly 15 years with Merck at three locations worldwide.
My Moon Shot - MD Anderson Cancer Center
As executive director and head of drug discovery at the Institute for Applied Cancer Science (IACS0, Jones leads a team of drug discovery and development scientists who aim to identify the next generation of cancer medicines, move them into …
- [PDF]
Philip Jones, Ph.D.
Philip Jones, Ph.D. Dr. Jones is Vice President for Therapeutics Discovery at MD Anderson Cancer Center, and Head of Drug Discovery for the Institute of Applied Cancer Science (IACS).
Drug Hunter: Discovering New Frontiers in Cancer Treatments
As a self-proclaimed drug hunter, Phil Jones is on a mission to identify the next generation of cancer medicines that improve the lives of patients with cancer.
Philip Jones on LinkedIn: 2022 is off to a running start for our ...
2022 is off to a running start for our Therapeutics Discovery team at MD Anderson Cancer Center. I’m excited to share a new collaboration with Eisbach Bio…
Institute for Applied Cancer Science - MD Anderson Cancer Center
The Institute for Applied Cancer Science (IACS) is committed to apply our understanding of mechanisms driving tumor development and maintenance into the development of impactful small-molecule cancer drugs for our patients in need.
Philip Jones's research works | University of Texas MD Anderson …
Philip Jones's 108 research works with 4,851 citations and 15,147 reads, including: Discovery of IACS-52825, a Potent and Selective DLK Inhibitor for Treatment of Chemotherapy-Induced...
MD Anderson Cancer Center's new building designed for …
Sep 21, 2023 · Dr. Philip Jones, MD Anderson's vice president of research strategy and operations, said the center’s goal was to concentrate research talent in one area. Jones told the Houston Business...
Jones, Philip (Faculty Profile) - Gulf Coast Consortia
Mar 31, 2020 · Philip Jones, Ph.D., is a drug hunter that leads a multi-disciplinary team of scientists whose mission is to identify the next generation of cancer medicines, move those into clinical trials and hopefully into clinical practice.
ENJOY SCIENCE Webinar Series - MD Anderson Cancer Center
The MD Anderson Cancer Center ENJOY SCIENCE webinar series was developed to strengthen the connections between the scientific and medical community at MD Anderson, our colleagues, patients and friends from around the world. This series highlights the incredible research taking place at MD Anderson while showcasing leaders from our research ...